CSF Drain Placement for Aortic Aneurysm
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether placing a cerebrospinal fluid (CSF) drain before a specific type of aortic surgery can reduce the risk of spinal cord issues. It focuses on patients undergoing endovascular thoracoabdominal aneurysm repair, a procedure for treating large aortic bulges. The study investigates two approaches: some patients will receive a CSF drain before surgery, while others will receive it only if needed afterward. Suitable candidates for this trial are those scheduled for high-risk endovascular repair involving significant aortic coverage. As an unphased trial, this study offers patients the chance to contribute to innovative research that could improve surgical outcomes.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that cerebrospinal fluid drain placement is safe for aortic aneurysm patients?
Research has shown that placing a cerebrospinal fluid (CSF) drain as a preventive measure is generally well-tolerated by patients. In one study, complications occurred in about 9.6% of cases, with only a small portion (0.74%) being serious. A review of over 1,400 patients found the procedure mostly safe, though it carries some risks.
Rare issues include bloody taps, which can delay surgery, blockages in the catheter, and bleeding in the spine. However, these problems are uncommon.
Overall, while some risks exist, the procedure is generally safe for most patients.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores whether placing a cerebrospinal fluid (CSF) drain before endovascular aortic repair can make a difference in preventing spinal cord ischemia. Typically, patients only receive a CSF drain after surgery if symptoms of spinal cord ischemia appear. This study aims to find out if a proactive approach with a prophylactic CSF drain could reduce the risk of complications, offering a potential improvement over the current reactive standard of care. By investigating this method, researchers hope to enhance patient outcomes by preventing issues rather than just treating them after they occur.
What evidence suggests that cerebrospinal fluid drain placement is effective for preventing spinal cord ischemia?
Research suggests that a preventive cerebrospinal fluid (CSF) drain might lower the risk of spinal cord ischemia (SCI), a condition where the spinal cord doesn't receive enough blood. In this trial, participants in the experimental arm will receive a prophylactic CSF drain placement before their endovascular aortic repair. One study showed that using CSF drainage beforehand reduced the chances of paraplegia (paralysis of the legs and lower body) after aneurysm repair. However, a review of multiple studies found no significant difference in SCI rates when using CSF drainage preventively compared to not using it. Participants in the control arm will not receive a prophylactic CSF drain but may receive one post-operatively as needed. The benefit appears most noticeable in high-risk patients, such as those with previous aortic aneurysm repairs. Overall, while some positive evidence exists, the effectiveness of preventive CSF drains is not yet fully confirmed.34678
Who Is on the Research Team?
Adam Beck, MD
Principal Investigator
University of Alabama at Birmingham
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are undergoing a high-risk procedure to repair an extensive thoracoabdominal aortic aneurysm. It's not for those in prison, pregnant, extremely ill ('moribund'), with ruptured aneurysms, needing urgent repairs, or with blood clotting issues that prevent safe placement of a CSF drain.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo endovascular thoracoabdominal aortic aneurysm repair with either prophylactic or selective cerebrospinal fluid drain placement
Follow-up
Participants are monitored for the onset of spinal cord ischemia and other complications post-operatively
What Are the Treatments Tested in This Trial?
Interventions
- Cerebrospinal Fluid Drain Placement
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
University of Massachusetts, Worcester
Collaborator
The University of Texas Health Science Center, Houston
Collaborator